Iowanews Headlines

Atopic Dermatitis Clinical, Companies, Therapy Assessment, Therapies, Pipeline | Vanda Pharmaceuticals, TechnoDerma Medicines, Asana BioSciences, Artax Biopharma, Corvus Pharmaceuticals, Yuhan, BioVer

Atopic Dermatitis Clinical, Companies, Therapy Assessment, Therapies, Pipeline | Vanda Pharmaceuticals, TechnoDerma Medicines, Asana BioSciences, Artax Biopharma, Corvus Pharmaceuticals, Yuhan, BioVer

Atopic Dermatitis Clinical Trials DelveInsight’s, “Atopic Dermatitis – Pipeline Insight, 2025” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Atopic Dermatitis pipeline landscape. It covers the

Read Full Article

Hypertriglyceridemia Clinical, Companies, Therapy Assessment, Therapies, Pipeline| NorthSea Therapeutics, Arrowhead Pharmaceuticals, Zhejiang Doer Biologics, Ionis Pharmaceuticals, GeneCradle, MediciN

Hypertriglyceridemia Clinical Trials DelveInsight’s, “Hypertriglyceridemia – Pipeline Insight, 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Hypertriglyceridemia pipeline landscape. It covers the pipeline drug profiles,

Read Full Article

Parkinson’s Disease Market Analysis 2034 – Competitive Landscape, Clinical Trials, Market Share, Medication, Patient Population, Companies by DelveInsight

Parkinson’s Disease Market Parkinson’s Disease Companies are Amneal Pharmaceuticals, AbbVie, Newron Pharmaceuticals, Zambon, Eisai, Kyowa Kirin, AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal Pharmaceutical, Pharma Two B, Jazz Pharmaceuticals, Chase

Read Full Article

EGFR Non Small Cell Lung Cancer Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Bridge Biotherapeutics, Sichuan Kelun Pharma, BeBetter Med

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ EGFR Non Small Cell

Read Full Article

Glioblastoma Multiforme Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Glioblastoma Multiforme pipeline constitutes key companies continuously working towards developing

Read Full Article

Hodgkin Lymphoma Pipeline Outlook Report 2025: Tracking the Most Promising Drugs in Clinical Development | DelveInsight

DelveInsight’s “Hodgkin Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in the Hodgkin

Read Full Article

Open-angle Glaucoma Pipeline Outlook Report 2025: Tracking the Most Promising Drugs in Clinical Development | DelveInsight

DelveInsight’s “Open-angle Glaucoma Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Open-angle

Read Full Article

Pathways to Inner Peace, Finding Connection, Inspiration, and Renewal in Challenging Times, A Nine-week Journey to Hope

“The fact is that we cannot control everything in life, including the weather, the news, and other people. In a

Read Full Article

Relapsing Refractory Multiple Myeloma Pipeline Therapeutics Landscape 2025: Key Clinical Advancements and R&D Breakthroughs by DelveInsight

DelveInsight’s, “Relapsed/Refractory Multiple Myeloma Pipeline Insight, 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the

Read Full Article

Menina Fortunato Interviews Debbie Gibson, JoJo Siwa, Abby Lee Miller, and Industry Icons at the 2025 Gala of the Stars

The Business of Dance Podcast host captures exclusive red carpet interviews at the Beverly Hilton charity gala benefiting Dancers Against

Read Full Article

Categories